News and publishing service for psychedelic related companies
Contact us:
512.354.7000
twitter
facebook
linkedin
News and publishing service for psychedelic related companies
Home
About
Clients
NewsRoom
Solutions
Events
Contact
PNW Headlines
NRx Pharmaceuticals Inc. (NRXP) Secures FDA Fast Track for IV Ketamine Formulation NRX-100 in Suicidal Depression
NRx Pharmaceuticals Inc. (NRXP) Subsidiary to Acquire 49% Stake in Prominent Florida Neuropsychiatry Clinic
NRx Pharmaceuticals Inc. (NRXP) Pursues Dual Pathway for Preservative-Free Ketamine-Based Therapies
NRx Pharmaceuticals Inc. (NRXP) Gains FDA Nod for Preservative-Free Ketamine Suitability Petition
NRx Pharmaceuticals Inc. (NRXP) Seeks FDA Ban on Toxic Ketamine Preservative
PsychedelicNewsBreaks
PsychedelicNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Reports Q3 Results and Advances NRX-100 and NRX-101 Regulatory Programs
NRx Pharmaceuticals, Inc. (NRXP)
November 17, 2025
PsychedelicNewsBreaks – NextPlat Corp. (NASDAQ: NXPL, NXPLW) Reports Q3 2025 Results Highlighted by Cost Reductions and Improving Healthcare Trends
NextPlat Corp. (NXPL)
November 13, 2025
PsychedelicNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Report Q3 2025 Financial Results and Host Conference Call on Nov. 17
NRx Pharmaceuticals Inc. (NRXP)
November 12, 2025
PsychedelicNewsBreaks – From San Francisco to Serbia: Global Psychedelic Week Sparks Worldwide Connection
Global Psychedelic Week (GPS)
November 3, 2025
PsychedelicNewsBreaks – NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Advances KETAFREE(TM), Expands Pipeline Targeting Urgent Needs
NRx Pharmaceuticals Inc. (NRXP)
October 16, 2025
View More PsychedelicNewsBreaks
PsychedelicNewsWire Articles
NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Pursues Dual Pathway for Preservative-Free Ketamine-Based Therapies
NRx Pharmaceuticals, Inc. (NRXP)
October 16, 2025
Global Psychedelic Week 2025 to Unite 5,000 People Across 100 Countries
Global Psychedelic Week
October 14, 2025
NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Gains FDA Nod for Preservative-Free Ketamine Suitability Petition
NRx Pharmaceuticals, Inc. (NRXP)
October 7, 2025
NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Secures FDA Fast Track for IV Ketamine Formulation NRX-100 in Suicidal Depression
NRx Pharmaceuticals, Inc. (NRXP)
September 2, 2025
NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Seeks FDA Ban on Toxic Ketamine Preservative
NRx Pharmaceuticals, Inc. (NRXP)
August 22, 2025
View All PsychedelicNewsWire Articles
Public Press Releases
Filter Releases
Filters
Sector
Aerospace and Defense
Banking and Finance
Banking
Biotechnology
Internet
Media
Metal and Mineral
Medical Marijuana
Chemicals
Computer
Consumer Goods
Pharmaceutical
Oil & Energy
Real Estate
Software
Energy
Entertainment
Food and Beverage
Healthcare
Telecommunications
Transportation
Utilities
Remove All Filters
Symbol
Release
Time
Source
{{ release.qmtopics.qmsymbol[0].symbol }}
{{ release.headline }}
{{ release.datetime | amDateFormat:'hh:mm A'}}
{{ release.source }}
Load More
PsychedelicNewsWire Currently Accepts
Bitcoin
Bitcoin Cash
Dogecoin
Ethereum
Litecoin
USD Coin
Contact us:
512.354.7000